1. Introduction
===============

Alzheimer's disease (AD) is the most common neurodegenerative disease \[[@B1-ijms-15-20876]\], which is characterized by cognitive decline, memory dysfunction and behavioral impairments \[[@B2-ijms-15-20876]\]. Epidemiological studies indicate that a high saturated fat dietary pattern is associated with cognitive decline and neurodegenerative diseases (NDs) \[[@B3-ijms-15-20876],[@B4-ijms-15-20876],[@B5-ijms-15-20876]\]. Clinical studies also showed that people in the upper fifth of saturated fatty acid (FA; SFA) intake had 2.2-times the risk of AD incidence compared to people in the lowest fifth \[[@B6-ijms-15-20876]\]. Furthermore, brains and cerebrospinal fluid (CSF) of AD patients are also characterized by elevated SFAs compared to healthy controls \[[@B7-ijms-15-20876],[@B8-ijms-15-20876]\]. Therefore, increased SFAs in the brain and CSF may contribute to AD pathology \[[@B8-ijms-15-20876]\]. Pathological changes in AD include beta-amyloid accumulation and beta-secretase activation, which play important roles in controlling synaptic activity and triggering neuronal apoptosis \[[@B9-ijms-15-20876]\].

Recent studies showed that palmitic acid (PA), a 16:0 SFA, is significantly elevated in brains of AD patients \[[@B7-ijms-15-20876]\]. PA is the most common saturated long-chain FA in food \[[@B10-ijms-15-20876]\] and is rich in plant and animal products, like palm oil, coconut oil, cheese, butter and lard \[[@B11-ijms-15-20876]\]. According to animal and human studies, diets high in PA induce cognitive decline \[[@B12-ijms-15-20876],[@B13-ijms-15-20876],[@B14-ijms-15-20876]\]; recent *in vitro* studies also showed that PA treatment induces neuronal cell apoptosis \[[@B15-ijms-15-20876],[@B16-ijms-15-20876]\], which suggests that PA may accelerate the pathologies of NDs \[[@B17-ijms-15-20876],[@B18-ijms-15-20876],[@B19-ijms-15-20876]\]. There are two sources of brain PA: dietary PA and *de novo* lipogenesis \[[@B20-ijms-15-20876]\]. Dietary PA can be transported through the vascular system and pass through the blood-brain-barrier \[[@B21-ijms-15-20876]\]. It was found that both PA and oleic acid (OA) are elevated in AD patients' brains \[[@B7-ijms-15-20876]\]. Further studies then examined whether PA and OA elevation affected AD development, and the results indicated that PA induction caused AD-like pathological changes and cell apoptosis in primary cortical neurons, whereas OA treatment did not induce such changes or neuronal cell death \[[@B22-ijms-15-20876],[@B23-ijms-15-20876],[@B24-ijms-15-20876]\].

A connection between AD and type 2 diabetes (T2D) was suggested \[[@B25-ijms-15-20876],[@B26-ijms-15-20876]\]. Since observational studies showed that patients with T2D have higher risks of AD development, researchers begun revealing pathogenic pathways shared by AD and T2D \[[@B27-ijms-15-20876],[@B28-ijms-15-20876]\]. One of the shared characteristics of AD and T2D is hyperglycemia. It was found that subjects with impaired glycemic control have higher cognitive decline than subjects with normal glycemic control \[[@B29-ijms-15-20876]\]. Moreover, high-fat diet-induced hyperglycemia was correlated with the development of AD pathology in rodents \[[@B30-ijms-15-20876]\]. Hyperglycemia induces the elevation of PA through lipogenesis \[[@B31-ijms-15-20876],[@B32-ijms-15-20876]\], which is also one of the main sources of elevated blood SFA levels. In addition, T2D patients with poor glycemic control exhibited higher levels of SFAs in the blood and lower cognitive function \[[@B33-ijms-15-20876],[@B34-ijms-15-20876],[@B35-ijms-15-20876]\]. SFAs, especially PA, induced neurotoxicity in cell culture. Therefore, deterioration of memory function in T2D patients may be associated with elevated blood SFAs \[[@B24-ijms-15-20876],[@B36-ijms-15-20876],[@B37-ijms-15-20876]\]. Studies indicated that the longer patients suffer from diabetes, the greater chances they have of developing AD \[[@B38-ijms-15-20876],[@B39-ijms-15-20876],[@B40-ijms-15-20876],[@B41-ijms-15-20876]\].

Cell cycle regulation is an essential process of cell growth, differentiation and proliferation in neurons \[[@B42-ijms-15-20876]\]. Dysregulation of the cell cycle causes neuronal cell dysfunction and cell death \[[@B43-ijms-15-20876],[@B44-ijms-15-20876]\]. Studies also demonstrated that PA treatment is related to the disruption of the cell cycle in pancreatic beta-cell and hepatic cells \[[@B45-ijms-15-20876],[@B46-ijms-15-20876],[@B47-ijms-15-20876]\]. In addition, studies also supported a role of endoplasmic reticular (ER) stress in SFA-induced cell death \[[@B45-ijms-15-20876]\]. In other aspects, dysregulation of protein palmitoylation was suggested as participating in PA-induced ER stress and beta-cell toxicity \[[@B48-ijms-15-20876]\]. Palmitoylation is a process of adding the 16-carbon SFA, palmitate, via thioester linkage to a cysteine residue, which regulates neuronal protein trafficking and function \[[@B49-ijms-15-20876]\]. The purpose of this study was to investigate whether the SFA, PA, induces neuronal toxicity via disturbing the cell cycle and the role of palmitoylation in PA-induced ER stress in SH-SY5Y human neuroblastoma cells.

2. Results and Discussion
=========================

2.1. Incorporation of FAs into SH-SY5Y Cells
--------------------------------------------

FA uptake was analyzed by gas chromatography. As shown in [Figure 1](#ijms-15-20876-f001){ref-type="fig"}A, the PA content significantly increased in cells compared to the control group after 3, 6, 10, 20 and 24 h of incubation with 0.3 mM PA (*p* \< 0.05). The PA content increased by 69% ± 12%, 138% ± 27%, 185% ± 34%, 246% ± 45% and 346% ± 67%, respectively, in SH-SY5Y after 3, 6, 10, 20 and 24 h of incubation with 0.3 mM PA ([Figure 1](#ijms-15-20876-f001){ref-type="fig"}A). On the other hand, the OA content also increased by 57% ± 12%, 243% ± 27%, 300% ± 34%, 400% ± 45% and 471% ± 67%, respectively, after 3, 6, 10, 20 and 24 h of incubation with 0.3 mM OA ([Figure 1](#ijms-15-20876-f001){ref-type="fig"}B). These data suggested that FA uptake was elevated by FA treatment in SH-SY5Y cells. The treated FAs, including PA and OA, were incorporated into SH-SY5Y cells from the medium and reached significant levels after 3 h of incubation.

###### 

Relative fatty acid contents of SH-SY5Y cells treated with palmitic acid (PA) or oleic acid (OA) at 0, 3, 6, 10, 20 and 24 h. The fatty acid composition was analyzed by gas chromatography after 0\~24 h of incubation with (**A**) 0.3 mM PA and (**B**) 0.3 mM OA. Data were analyzed by a one-way analysis of variance (ANOVA), followed by the LSD test, and are presented as the mean ± SD. \* *p* \< 0.05, \*\* *p* \< 0.01 *vs.* the control group (*n* = 3).
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2.2. Effects of PA and OA on SH-SY5Y Cell Viability
---------------------------------------------------

The effects of PA and OA on the viability of SH-SY5Y cells were evaluated using an MTT assay. As shown in [Figure 2](#ijms-15-20876-f002){ref-type="fig"}, treatment with 0.2\~0.5 mM PA resulted in a significant decrease in cell viability after incubation for 24 and 48 h. On the contrary, OA treatment at 0.2\~0.5 mM for 24 and 48 h did not alter cell viability. PA significantly impaired the viability of SH-SY5Y cells in dose- and time-dependent manners at concentrations of 0.2, 0.3 and 0.5 mM for 24 and 48 h (*p* \< 0.05) ([Figure 2](#ijms-15-20876-f002){ref-type="fig"}). Compared to results at 24 h, the viability of SH-SY5Y cells had significantly decreased at 48 h at doses of PA of 0.3 and 0.5 mM (*p* \< 0.05) ([Figure 2](#ijms-15-20876-f002){ref-type="fig"}).

![The effects of palmitic acid (PA) and oleic acid (OA) on cell viability of SH-SY5Y cells. SH-SY5Y cells were treated with the vehicle control (0 mM), 0.2\~0.5 mM PA, or 0.2\~0.5 mM OA for 24 and 48 h. After treatment, cell viability was measured by an MTT assay. All treatment conditions were normalized to the control group. Data were analyzed by a one-way ANOVA, followed by the LSD test, and are presented as the mean ± SD. \*\* *p* \< 0.01 *vs.* the control group.](ijms-15-20876-g002){#ijms-15-20876-f002}

2.3. Effects of PA on SH-SY5Y Cell Morphology
---------------------------------------------

We next observed morphological alterations of SH-SY5Y cells treated with different concentrations of PA and OA for 24 and 48 h. As shown in [Figure 3](#ijms-15-20876-f003){ref-type="fig"}, SH-SY5Y cells exhibited obvious morphological changes after treatment with 0.3 mM PA for 24 h ([Figure 3](#ijms-15-20876-f003){ref-type="fig"}A). The morphology of the PA-treated group showed larger cell sizes and fading synapses, and cells were unattached to the culture dish ([Figure 3](#ijms-15-20876-f003){ref-type="fig"}A). In order to confirm the visual observations, we further measured the cell size using flow cytometry ([Figure 3](#ijms-15-20876-f003){ref-type="fig"}B,C). We found that the cell size was significantly larger in the group treated with 0.3 mM PA after 24 h of incubation, but not after 48 h of incubation ([Figure 3](#ijms-15-20876-f003){ref-type="fig"}C).

###### 

Effects of palmitic acid (PA) and oleic acid (OA) on SH-SY5Y cell morphology. (**A**) Cells were treated with the vehicle control (Cntrl), 0.3 mM OA or 0.3 mM PA for 24 (**top**) and 48 h (**bottom**) and then imaged with a microscope; (**B**) effects of PA and OA on the SH-SY5Y cell size. Cells were treated with the vehicle (Cntrl), 0.3 mM OA or 0.3 mM PA for 24 (**top**) and 48 h (**bottom**), then measured with flow cytometry; (**C**) Effects of PA and OA on the SH-SY5Y cell volume. Cells were treated with PA or OA for 24 and 48 h, and then, the cell volume was quantified by flow cytometry. Data were analyzed by a one-way ANOVA, followed by the LSD test, and are presented as the mean ± SD. \* *p* \< 0.05 *vs.* the Cntrl (*n* = 3).
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On the other hand, OA treatment did not alter the morphology of SH-SY5Y cells. After incubation with 0.3 mM OA, the OA-treated group showed no differences in morphology compared to the control. Furthermore, we also evaluated the cell volume by flow cytometry to confirm our visual findings. The mean cell volume ([Figure 3](#ijms-15-20876-f003){ref-type="fig"}C) of the PA-treated group was significantly elevated to 140% ± 16% at 24 h (*p* \< 0.05). Groups treated with OA exhibited no significant difference compared to the control.

2.4. Cell Cycle G~2~/M Arrest Induced by PA in SH-SY5Y Cells
------------------------------------------------------------

In the cell cycle examination, we found that PA dramatically induced cell cycle arrest at the G~2~/M phase after treatment with 0.3 mM PA for 24 h ([Figure 4](#ijms-15-20876-f004){ref-type="fig"}). Fluorescence integration of the G~2~/M phase significantly increased (*p* \< 0.01), while the G~0~G~1~ phase significantly decreased (*p* \< 0.05) after treatment with 0.3 mM PA for 24 h ([Figure 4](#ijms-15-20876-f004){ref-type="fig"}C), indicating that cells had lower rates of growth and tended to be arrested at the G~2~/M transition. In addition, the 0.1-mM PA-treated group did not exhibit significant G~2~/M arrest, which suggests that the lower dose of PA had minor effects on the neuronal cell cycle ([Figure 4](#ijms-15-20876-f004){ref-type="fig"}B). On the contrary, OA treatment did not disturb the cell cycle; neither the G~0~G~1~ phase nor G~2~/M phase differed from the control group after 24 and 48 h of incubation with OA ([Figure 4](#ijms-15-20876-f004){ref-type="fig"}B,C). In addition to G~2~/M arrest, we further observed increased apoptotic cells, indicated by an increase in the subG~1~ phase, after treatment with 0.3 mM PA for 48 h by flow cytometry ([Figure 4](#ijms-15-20876-f004){ref-type="fig"}C). While significant cell apoptosis was observed after treatment with 0.3 mM PA for 48 h, SH-SY5Y cells showed reduced growth as indicated by reduced rates of the G~0~/G~1~ phase. Based on the above results, these observations provide evidence that PA and OA have distinct effects on the SH-SY5Y cell cycle and indicate that chronic exposure of SH-SY5Y to PA evoked significant G~2~/M arrest prior to neuronal apoptosis. We are the first group to observe neuronal cell cycle G~2~/M arrest evoked by the SFA, PA, and so, we then worked to find the possible cause of the G~2~/M arrest induced by PA.

###### 

Effects of palmitic acid (PA) and oleic acid (OA) on the SH-SY5Y cell cycle. (**A**) Cells were treated with the vehicle control (Cntrl), 0.3 mM PA or 0.3 mM OA for 24 (**top**) and 48 h (**bottom**). The cell cycle was then analyzed by flow cytometry; (**B**) Quantified data are shown as the percentages of the four phases divided by the DNA content in the cell cycle. SH-SY5Y cells were treated with the vehicle control (Cntrl), 0.1 mM PA or 0.1 mM OA for 24 (**top**) and 48 h (**bottom**) and (**C**) Cells were treated with the vehicle control (Cntrl), 0.3 mM PA or 0.3 mM OA for 24 (**top**) and 48 h (**bottom**). Data were analyzed by a one-way ANOVA, followed by the LSD test, and are presented as the mean ± SD. \* *p* \< 0.05 *vs* the Cntrl group. \*\* *p* \< 0.01 *vs* the Cntrl group (*n* = 3).
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2.5. ER Stress and Beta-Amyloid Accumulation Induced by PA
----------------------------------------------------------

ER stress was suggested to play an important role in SFA-induced lipotoxicity \[[@B50-ijms-15-20876],[@B51-ijms-15-20876]\]. To further examine the effects of PA on ER stress, we analyzed the protein expression of p-eIF2a, an ER stress marker, in PA-treated cells. We found that ER stress significantly increased in the PA-treated group ([Figure 5](#ijms-15-20876-f005){ref-type="fig"}A), which indicates that G~2~/M arrest in neuronal cells might be a result of PA-induced ER stress. Furthermore, PA also stimulated beta-secretase protein expression and beta-amyloid accumulation in SH-SY5Y cells ([Figure 5](#ijms-15-20876-f005){ref-type="fig"}B), especially after 48 h of PA treatment. These data demonstrated that PA-induced neuronal apoptosis was similar to that in a cell model of AD. On the contrary, OA induction did not induce beta-secretase protein expression or beta-amyloid accumulation in any of the OA-treated groups.

![Effects of palmitic acid (PA) and oleic acid (OA) on Alzheimer's disease pathology-related protein expression and an endoplasmic reticular (ER) stress marker. (**A**) SH-SY5Y cells were treated with 0.1\~0.3 mM PA or OA for 24 (**left**) or 48 h (**right**). Cells were then harvested for the analysis of protein expression of the ER stress marker, p-eukaryotic initiation factor 2-alpha (p-eIF2α) and (**B**) SH-SY5Y cells were incubated with PA or OA for 48 h. Cells were then harvested for examination of beta-amyloid protein expression (**left**). SH-SY5Y cells were incubated with PA or OA for 48 h, and then, the beta-secretase protein expression was examined (**right**). Data were analyzed by a one-way ANOVA, followed by the LSD test, and are presented as the mean ± SD. \* *p* \< 0.05 *vs* the control (0 mM PA; 0 mM OA). \*\* *p* \< 0.01 *vs* the control (0 mM PA; 0 mM OA) (*n* = 3).](ijms-15-20876-g005){#ijms-15-20876-f005}

2.6. Antioxidants and a PKC Inhibitor could not Alleviate PA-Induced Cell Death
-------------------------------------------------------------------------------

Our results suggested that PA induced G~2~/M arrest through the induction of ER stress. It was shown that oxidative stress is involved in cell cycle G~2~/M arrest and ER stress induction \[[@B52-ijms-15-20876]\]. Since phenolic acids and vitamin C are known for their antioxidative abilities, they were used to observe if PA-induced cell death could be alleviated through antioxidants in our study. However, pretreatment with antioxidants 1 h before treatment with 0.3 mM PA did not reverse PA-induced cell death in our study ([Figure 6](#ijms-15-20876-f006){ref-type="fig"}A), which suggested that antioxidation might not play a key role in the cytotoxicity induced by PA in SH-SY5Y cells. Cell viability showed no difference between the group with and that without antioxidants under PA treatment.

PKC was also suggested to be involved in cell cycle G~2~/M arrest and ER stress \[[@B53-ijms-15-20876],[@B54-ijms-15-20876]\]. Calphostin C, a broad PKC inhibitor \[[@B55-ijms-15-20876]\], was used in this study. However, calphostin C pretreatment did not reverse PA-induced cell death ([Figure 6](#ijms-15-20876-f006){ref-type="fig"}B), which indicates that PA-induced cell death did not mainly occur through PKC activation. Pretreatment with either a PKC inhibitor or antioxidants did not alleviate PA-induced cell death. Nevertheless, we found that pretreatment with 2-BP, a protein palmitoylation inhibitor, reversed cell viability after 24 and 48 h of treatment with 0.3 mM PA in SH-SY5Y cells ([Figure 6](#ijms-15-20876-f006){ref-type="fig"}C). Moreover, the beneficial actions of 2-BP were concentration related, with 0.3 mM 2-BP providing maximal protection after treatment with PA for 24 and 48 h ([Figure 6](#ijms-15-20876-f006){ref-type="fig"}C).

###### 

Effects of antioxidants, a protein kinase C (PKC) inhibitor (calphostin C; Calph) and a palmitoylation inhibitor (2-bromopalmitate; 2-BP) on PA-induced cell death. (**A**) SH-SY5Y cells were treated with antioxidants, including polyphenols and vitamin C, 1 h before treatment with 0.3 mM PA. The cell viability of different groups was normalized to the control group (no PA); (**B**) SH-SY5Y cells were treated with the PKC inhibitor, Calph, for 1 h before treatment with 0.3 mM PA and light activation. The final concentrations of Calph were 0.01\~1 μM. Cell viability of SH-SY5Y cells was normalized to the control (0 μM Calph); (**C**) Cells were treated with the palmitoylation inhibitor, 2-BP, 1 h before treatment with 0.3 mM PA and then were incubated for 24 and 48 h. Cell viability was normalized to the control (0 mM 2-BP without PA treatment). Data were analyzed by a one-way ANOVA, followed by the LSD test, and are presented as the mean ± SD. \* *p* \< 0.05, \*\* *p* \< 0.01 *vs* the control group (*n* = 3).
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2.7. A Protein Palmitoylation Inhibitor Attenuated PA-Induced G~2~/M Arrest and ER Stress
-----------------------------------------------------------------------------------------

Since 2-BP was effective at preventing cell death in response to PA, the effects of 2-BP on the cell cycle were also examined. As a result, 2-BP significantly attenuated G~2~/M arrest induced by PA (*p* \< 0.05) ([Figure 7](#ijms-15-20876-f007){ref-type="fig"}A), whereas OA treatment did not ([Figure 7](#ijms-15-20876-f007){ref-type="fig"}B). In addition, pretreatment with 2-BP mitigated ER stress induced by PA (*p* \< 0.05) ([Figure 7](#ijms-15-20876-f007){ref-type="fig"}C). These findings suggest that aberrant protein palmitoylation may contribute to PA toxicity toward neuronal cells. When examining other possible pathways by which PA activates ER stress and G~2~/M arrest, we found that treatment with the protein palmitoylation inhibitor, 2-BP, prevented PA-mediated ER stress induction and G~2~/M arrest, indicating that protein palmitoylation is pivotal to this process.

![Effects of a protein palmitoylation inhibitor on palmitic acid (PA)-induced cell cycle disturbance and endoplasmic reticular (ER) stress. (**A**) SH-SY5Y cells were treated with the vehicle (Cntrl) and 0.3 mM PA with or without 2-bromopalmitate (2-BP) for 24 and 48 h, and then, the cell cycle was examined by flow cytometry; (**B**) SH-SY5Y cells were treated with the vehicle (Cntrl) and 0.3 mM OA with or without 2-BP for 24 and 48 h, and the cell cycle was examined by flow cytometry; (**C**) effects of a protein palmitoylation inhibitor on ER stress in PA-treated SH-SY5Y cells at 24 h. Data were analyzed by a one-way ANOVA, followed by the LSD test, and are presented as the mean ± SD. \* *p* \< 0.05, \*\* *p* \< 0.01 *vs* the Cntrl; ^†^ *p* \< 0.05 *vs* groups with PA without 2-BP. (*n* = 3).](ijms-15-20876-g007){#ijms-15-20876-f007}

2.8. Discussion
---------------

The present study elucidates the effects of PA on SH-SY5Y cell apoptosis and includes three main findings. Firstly, we demonstrated that PA caused conspicuous morphological changes in SH-SY5Y human neuroblastoma cells. A relatively larger cell volume was observed after exposure to PA. Secondly, we found that the changes in the volume of cells occurred along with the arrest of the cell cycle at the G~2~/M phase ([Figure 3](#ijms-15-20876-f003){ref-type="fig"} and [Figure 7](#ijms-15-20876-f007){ref-type="fig"}). We provide the first direct evidence that PA induces G~2~/M arrest through protein palmitoylation. Thirdly, we characterized the importance of protein palmitoylation in PA-induced ER stress, G~2~/M arrest and neuronal cell apoptosis. Together, these findings contribute to the understanding of the mechanism(s) in which PA decreases neuronal cell survival.

Studies have shown that elevated SFA levels are associated with the pathological development of neurological disorders \[[@B13-ijms-15-20876],[@B56-ijms-15-20876],[@B57-ijms-15-20876],[@B58-ijms-15-20876]\]. For instance, a high-SFA diet and an elevation of plasma SFA were proposed to be risk factors for NDs, especially AD \[[@B6-ijms-15-20876],[@B59-ijms-15-20876]\]. SFAs, such as PA and stearic acid (SA), can cause deleterious effects in many cell types \[[@B15-ijms-15-20876],[@B24-ijms-15-20876],[@B60-ijms-15-20876],[@B61-ijms-15-20876],[@B62-ijms-15-20876],[@B63-ijms-15-20876]\], with apoptosis being the most common phenomenon \[[@B63-ijms-15-20876],[@B64-ijms-15-20876]\]. Therefore, it is critical to investigate possible mechanisms of PA-induced neuronal apoptosis. In this study, we selected PA as a representative SFA to explore its effects on neuronal SH-SY5Y cells, while OA was used as a reference. Though OA was indicated to have different effects at certain concentrations (0.1 and 0.3 mM) under the diabetic cell model \[[@B65-ijms-15-20876]\], we did not find any adverse effect in our study.

In the present study, we found that the fluorescent intensity of the G~2~/M phase substantially increased, which indicates a growth/mitosis-arrested status in SH-SY5Y cells after 24 h of PA incubation. Recent studies also showed that PA induced apoptosis in neuronal cells \[[@B15-ijms-15-20876],[@B23-ijms-15-20876],[@B66-ijms-15-20876],[@B67-ijms-15-20876]\]. Herein, we showed that direct G~2~/M arrest occurs in neuronal cells exposed to PA. It was proposed that neuronal apoptosis detected in NDs, such as AD, was related to the blockade of the cell cycle at the G~2~/M phase \[[@B43-ijms-15-20876]\]. However, in acute central nervous system (CNS) injury, such as stroke and trauma, the cell cycle is arrested at the G~1~/S transition, which indicates that the adverse alterations induced by PA are similar to NDs, rather than acute injury to neuronal cells \[[@B43-ijms-15-20876]\]. Since the G~2~/M arrest occurs prior to apoptosis \[[@B68-ijms-15-20876],[@B69-ijms-15-20876],[@B70-ijms-15-20876]\], we inferred that G~2~/M arrest led to neuronal apoptosis in PA-treated SH-SY5Y cells, which results in a decrement in cell size. Sustained elevation of PA in the brain is known to cause deterioration of neuronal cell viability \[[@B71-ijms-15-20876],[@B72-ijms-15-20876]\]. One key mechanism in SFA-mediated cell stress is ER stress \[[@B15-ijms-15-20876],[@B73-ijms-15-20876]\]. A previous study also suggested that G~2~/M arrest can be induced by ER stress in non-neuronal cells \[[@B70-ijms-15-20876]\]; therefore, we suggest that the G~2~/M arrest appearing in SH-SY5Y cells may be involved in ER stress. In agreement with previous findings, we found that PA was able to increase the ER stress marker, p-eIF2α, and promote cell death. We also demonstrated that PA accelerates AD-like pathological changes in SH-SY5Y cells, such as the accumulation of beta-amyloid ([Figure 5](#ijms-15-20876-f005){ref-type="fig"}A) and the elevation of beta-secretase. Although previous studies reported that PA, through its uptake and metabolism by astrocytes, led to AD-like pathological changes in neurons \[[@B71-ijms-15-20876]\], our work demonstrated that PA can directly induce significant beta-amyloid accumulation and beta-secretase protein expression without stimulating astrocytes.

Oxidative stress is involved in cell-cycle G~2~/M arrest, ER stress induction and cell death \[[@B52-ijms-15-20876]\]. However, in our findings, antioxidants, like phenolic acid and vitamin C, could not reverse the lowered cell viability induced by PA. These data suggest that oxidative stress may play a marginal role in PA-induced cell death. PKC was also suggested to be involved in the cell cycle G~2~/M checkpoint in a breast cancer cell line \[[@B53-ijms-15-20876]\]. In addition, ER stress can be induced by the activation of the PKC isoforms, PKC-theta and PKC-delta \[[@B74-ijms-15-20876],[@B75-ijms-15-20876]\]. One study showed that neurons with higher expression of PKC were critical for nutrient sensing and were responsive to PA, suggesting that PA treatment may also be related to PKC activation, thus stimulating neuronal cell apoptosis \[[@B76-ijms-15-20876]\]. Another study also confirmed that inhibiting PKC activation downregulated cell apoptosis \[[@B77-ijms-15-20876]\]. Nevertheless, in the present study, the PKC inhibitor, calphostin C, could not reverse cell death induced by PA.

Protein palmitoylation is a post-translational process in which FAs, primarily PA, are bound to cysteine residues through thio-ester linkages \[[@B78-ijms-15-20876]\]. Protein palmitoylation regulates diverse aspects of neuronal protein trafficking and functions \[[@B49-ijms-15-20876]\]. A global study also identified 68 known neuronal palmitoylated proteins and 200 new candidates, including neurotransmitters, receptors and transporters, indicating that palmitoylation plays an extremely important role in regulating neuronal functions \[[@B49-ijms-15-20876]\]. Attachment of PA alters a protein's structure, hydrophobicity and translocation \[[@B79-ijms-15-20876]\]. Protein palmitoylation is also highly dynamic \[[@B80-ijms-15-20876]\] and regulates protein localization and functions in neuron synapses \[[@B81-ijms-15-20876]\]. Furthermore, proteins with cysteine residues can be palmitoylated *in vitro* in the presence of FAs \[[@B78-ijms-15-20876],[@B82-ijms-15-20876]\]. The spontaneous process of this modification suggests that protein palmitoylation may increase in the presence of elevated PA.

In the present study, we found that PA stimulated ER stress via protein palmitoylation in SH-SY5Y cells. Since ER is sensitive to aberrant proteins, uncontrolled protein palmitoylation could exacerbate ER stress \[[@B83-ijms-15-20876],[@B84-ijms-15-20876]\]. Previous studies associated ER stress with lipotoxicity \[[@B73-ijms-15-20876],[@B85-ijms-15-20876]\], and unregulated protein palmitoylation could be a potent activator of protein aggregation and ER stress \[[@B84-ijms-15-20876]\]. In our study, we applied 2-BP to examine the inhibitory effects of protein palmitoylation. 2-BP, a non-metabolized PA analog, blocks PA incorporation into proteins \[[@B86-ijms-15-20876],[@B87-ijms-15-20876],[@B88-ijms-15-20876]\].

In our results, 2-BP significantly attenuated the toxicity of PA toward SH-SY5Y cells. The effects of 2-BP on PA-induced ER stress were also examined. We also found that the PA-induced ER stress marker, p-eIF2α, was attenuated by treatment with 2-BP in SH-SY5Y cells. Since prolonged ER stress can culminate in G~2~/M blockage, we examined the effect of 2-BP on PA-induced G~2~/M arrest. Consistent with the attenuation of ER stress, the presence of 2-BP prevented PA-induced G~2~/M arrest. In conclusion, we provide evidence that suggests that the SFA, PA, induces deleterious effects on neuronal cells through protein palmitoylation. Taken together, these findings suggest that PA induces neuronal ER stress, G~2~/M arrest and cell apoptosis through protein palmitoylation.

3. Experimental Section
=======================

3.1. Cell Culture Preparation
-----------------------------

The SH-SY5Y human neuroblastoma cell line, a well-established cell model for studying ND diseases \[[@B89-ijms-15-20876]\], was purchased from American Type Culture Collection (ATCC, Manassas, VA, USA). Cells were cultured in minimum essential medium (MEM) supplemented with F12 (Gibco, Paisley, UK), 10% fetal bovine serum, 1% non-essential amino acids (NEAAs), sodium bicarbonate and 1% penicillin-streptomycin (pen/strep) at 37 °C in a 5% CO~2~ incubator. Fresh medium was changed every 2\~3 days. Each aliquot (vial) of cells was passed through no more than 10 passages. Experiments were performed at 50% cell confluence.

3.2. FA Treatment
-----------------

PA and OA were purchased from Sigma-Aldrich (Dorset, UK). The FA/bovine serum albumin (BSA) complex was prepared by a modified method \[[@B62-ijms-15-20876]\]. Briefly, 20 mM PA and OA stock solutions were prepared in 0.01 N NaOH by heating to 80 °C in a dry bath. Stocks were then added to MEM containing a 1% BSA solution to reach final concentrations of 0.1\~0.5 mM. Solutions were next vortex-mixed followed by a further incubation for 30 min at 37 °C. The PA and OA complex solutions were then immediately used to treat SH-SY5Y cells for 24 or 48 h according to the experimental design.

3.3. Cell Viability Assay
-------------------------

A 3-\[4,5-cimethylthiazol-2-yl\]-2,5-diphenyl tetrazolium bromide (MTT) assay was performed to determine the viability of SH-SY5Y cells under the influence of PA and OA \[[@B90-ijms-15-20876]\]. Briefly, 24 or 48 h following treatment with PA and OA, MTT was added to each well of a 24-well plate and incubated at 37 °C for 1 h. Purple-colored precipitates of the living cell metabolite, formazan, were then dissolved in 500 µL of dimethyl sulfoxide (DMSO) and were analyzed in 96-well plates. The color absorbance was recorded at 590 nm. Cell viability was calculated by the absorbance ratio of the treatment group over the control group.

3.4. Cell Size Measurement
--------------------------

The cell size of SH-SY5Y is determined by the intensity of forward light scattering (FSC), the extent of the size of the scattering cells, by flow cytometry. Briefly, SH-SY5Y cells were stained with propidium iodide (PI) solution and incubated in the dark for 30 min at 37 °C, then excited at 488 nm and measuring the emission at 580 nm in a flow cytometer. FSC for viable cells was generated on a computer from raw data files of flow cytometry.

3.5. FA Composition Analysis
----------------------------

To determine FA uptake by SH-SY5Y cells, total FAs were extracted by the widely used method of Folch *et al.* \[[@B91-ijms-15-20876]\]. Briefly, FAs were extracted with chloroform and methanol, and 0.02% CaCl~2~ was added to stabilize the phospholipids. Lysates were then vortex-mixed and centrifuged. A mixture of chloroform:methanol:water (3:48:47; 0.5 mL) was added to the supernatant. After further vortex-mixing and centrifugation, FAs extracted from the chloroform layer were dried in a vacuum evaporator. FAs were then transmethylated with 0.15 mL of 14% boron fluoride in methanol at 100 °C for 10 min \[[@B92-ijms-15-20876]\]. Then, samples were cooled on ice, pentane and water added and the two phases separated by centrifugation. The pentane phase was transferred to a new tube and dried in a vacuum evaporator. The methyl esters were dissolved in hexane and analyzed by Thermo Scientific Focus gas chromatography (GC) (Thermo Scientific, Courtaboeuf, France) \[[@B93-ijms-15-20876]\].

3.6. Cell Cycle Analysis
------------------------

The cell cycle was examined by a modified flow cytometric method \[[@B94-ijms-15-20876]\]. In brief, SH-SY5Y cells were harvested at 24 and 48 h. Harvested cells were washed twice with phosphate-buffered saline (PBS) and fixed in ice-cold 70% ethanol at 4 °C overnight. Ethanol-fixed cells were then stored at 4 °C for up to 1 month. Ethanol-fixed cells were centrifuged and washed once with PBS. The cell pellet was then suspended in 0.2 mL DNA extraction buffer (192 mL 0.2 M Na~2~HPO~4~ and 8 mL 0.1 M citric acid, pH 7.8) and incubated in a 37 °C shaker for 30 min. After incubation, cells were centrifuged at 1500 rpm for 10 min. The supernatant was carefully discarded. Then, the pellet was stained with a propidium iodide (PI) solution (0.08 mg PI, 0.1% triton X-100 and 0.1 mg/mL RNase A in PBS) and incubated in the dark for 30 min at 37 °C. In total, 10,000 cells (adherent and non-adherent) were harvested. Cellular DNA contents were measured by exciting PI at 488 nm and measuring the emission at 580 nm using a BD canto II flow cytometer (BD Biosciences, San Jose, CA, USA).

3.7. Immunoblotting
-------------------

To determine protein expressions by SH-SY5Y cells, cells were washed twice with PBS and solubilized in lysis buffer containing freshly added protease and phosphatase inhibitors. Protein aliquots were solubilized in Laemmli buffer and boiled at 95 °C for 5 min, and then, 10%\~15% sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE) was run. After electrophoresis, proteins were transferred to polyvinylidene difluoride (PVDF) membranes. The membranes were then blocked, washed and incubated with the antibody. Primary antibodies of p-eukaryotic translation inhibition factor 2α (p-eIF2α, 1:2000), beta-amyloid (1:2000) and beta-secretase (1:2000) were purchased from Cell Signaling Technology (Beverly, MA, USA). Target proteins were visualized using an enhanced chemiluminescence (ECL) system. Levels of beta-amyloid and beta-secretase were assessed by a densitometric analysis and normalized to the β-actin value.

3.8. Pretreatment with Antioxidants
-----------------------------------

In order to determine whether antioxidants are involved in PA-induced lipotoxicity, SH-SY5Y cells were incubated with 1\~100 μM of antioxidants, including anthocyanin, caffeic acid, catechin, chlorogenic acid, coumaric acid, ferulic acid, rutin, syringic acid, vitamin C and quercetin. The antioxidants were dissolved in either DMSO or PBS according to their solubility, and cells were treated 1 h prior to FA treatment. Anthocyanin was extracted from Oriental plums; the extraction method was adopted from our previous protocol \[[@B95-ijms-15-20876]\]. Caffeic acid, catechin, chlorogenic acid, coumaric acid, ferulic acid, rutin, syringic acid and vitamin C were purchased from Sigma-Aldrich (St. Louis, MO, USA), and quercetin was purchased from Wako Pure Chemical Industries (Osaka, Japan).

3.9. PKC Inhibitor Treatment
----------------------------

Calphostin C, a specific inhibitor of PKC \[[@B96-ijms-15-20876]\], was purchased from Enzo Life Sciences (BML-EI-198-0100, Lausen, Switzerland). Since inhibition of PKC by calphostin C is light dependent and ordinary fluorescent light is sufficient for full activation \[[@B97-ijms-15-20876]\], we exposed cells and medium containing 0.01\~1 µM calphostin C to ordinary fluorescent light for 1 h at room temperature. SH-SY5Y cells were then treated with FAs and incubated at 37 °C in a 5% CO~2~ incubator.

3.10. Palmitoylation Inhibitor Treatment
----------------------------------------

2-Bromopalmitate (2-BP), a widely used palmitoylation inhibitor \[[@B81-ijms-15-20876]\], is available from Sigma-Aldrich. A 100-mM stock was prepared in dimethyl sulfoxide (DMSO) and then diluted with media to final concentrations of 0.01\~1 mM. SH-SY5Y cells were then incubated with 0.01\~1 mM 2-BP to test its toxicity toward SH-SY5Y cells, and concentrations of 0.01\~0.3 mM were selected for the following study. During the experiment, cells were treated with 0.01\~0.3 mM 2-BP 1 h prior to FA treatment.

3.11. Statistical Analysis
--------------------------

Statistical analyses were performed using a one-way analysis of variance (ANOVA) followed by the least significant difference (LSD) test. A *p*-value of \<0.05 was considered statistically significant.

4. Conclusions
==============

Palmitic acid induced neuronal cell apoptosis, cell cycle G~2~/M arrest, beta-amyloid accumulation and the elevation of endothelial reticulum stress in SH-SY5Y human neuroblastoma cells. By inhibiting protein palmitoylation, the palmitic acid-induced cell apoptosis, cell cycle arrest and endothelial reticulum stress were significantly alleviated. These results suggest that protein palmitoylation plays an important role in palmitic acid-induced neurotoxicity.
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